• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜层变薄用于监测复发型多发性硬化症的疾病修正治疗——应用重新设定基线概念的证据。

Retinal layer thinning for monitoring disease-modifying treatment in relapsing multiple sclerosis-Evidence for applying a rebaselining concept.

机构信息

Department of Neurology, Medical University of Vienna, Vienna, Austria; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.

Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

出版信息

Mult Scler. 2024 Aug;30(9):1128-1138. doi: 10.1177/13524585241267257. Epub 2024 Aug 7.

DOI:10.1177/13524585241267257
PMID:39109593
Abstract

BACKGROUND

Employing a rebaselining concept may reduce noise in retinal layer thinning measured by optical coherence tomography (OCT).

METHODS

From an ongoing prospective observational study, we included patients with relapsing multiple sclerosis (RMS), who had OCT scans at disease-modifying treatment (DMT) start (baseline), 6-12 months after baseline (rebaseline), and ⩾12 months after rebaseline. Mean annualized percent loss (aL) rates (%/year) were calculated both from baseline and rebaseline for peripapillary-retinal-nerve-fiber-layer (aLpRNFL/aLpRNFL) and macular-ganglion-cell-plus-inner-plexiform-layer (aLGCIPL/aLGCIPL) by mixed-effects linear regression models.

RESULTS

We included 173 RMS patients (mean age 31.7 years (SD 8.8), 72.8% female, median disease duration 15 months (12-94) median baseline-to-last-follow-up-interval 37 months (18-71); 56.6% moderately effective DMT (M-DMT), 43.4% highly effective DMT (HE-DMT)). Both mean aLpRNFL and aLGCIPL significantly increased in association with relapse (0.51% and 0.26% per relapse, < 0.001, respectively) and disability worsening (1.10% and 0.48%, < 0.001, respectively) before baseline, but not with DMT class. Contrarily, neither aLpRNFL nor aLGCIPL was dependent on relapse or disability worsening before baseline, while HE-DMT significantly lowered aLpRNFL (by 0.31%, < 0.001) and aLGCIPL (0.25%, < 0.001) compared with M-DMT.

CONCLUSIONS

Applying a rebaselining concept significantly improves differentiation of DMT effects on retinal layer thinning by avoiding carry-over confounding from previous disease activity.

摘要

背景

采用重新基线化概念可以减少光学相干断层扫描(OCT)测量的视网膜层变薄中的噪声。

方法

我们纳入了正在进行的前瞻性观察性研究中的复发型多发性硬化症(RMS)患者,这些患者在疾病修正治疗(DMT)开始时(基线)、基线后 6-12 个月(重新基线)和重新基线后 ⩾12 个月时进行 OCT 扫描。通过混合效应线性回归模型,从基线和重新基线计算了视盘周围视网膜神经纤维层(aLpRNFL/aLpRNFL)和黄斑神经节细胞加内丛状层(aLGCIPL/aLGCIPL)的平均年化损失率(aL)(%/年)。

结果

我们纳入了 173 名 RMS 患者(平均年龄 31.7 岁(8.8 岁),72.8%为女性,中位疾病持续时间为 15 个月(12-94),中位基线至最后随访间隔为 37 个月(18-71);56.6%的患者接受了中度有效的 DMT(M-DMT),43.4%的患者接受了高效的 DMT(HE-DMT))。在基线之前,与复发(分别为 0.51%和 0.26%/复发,<0.001)和残疾恶化(分别为 1.10%和 0.48%,<0.001)相关,aLpRNFL 和 aLGCIPL 的平均值均显著增加,但与 DMT 类别无关。相反,在基线之前,aLpRNFL 和 aLGCIPL 均不受复发或残疾恶化的影响,而与 M-DMT 相比,HE-DMT 显著降低了 aLpRNFL(0.31%,<0.001)和 aLGCIPL(0.25%,<0.001)。

结论

通过避免以前疾病活动的残留混杂,应用重新基线化概念可显著改善 DMT 对视网膜层变薄的影响的区分。

相似文献

1
Retinal layer thinning for monitoring disease-modifying treatment in relapsing multiple sclerosis-Evidence for applying a rebaselining concept.视网膜层变薄用于监测复发型多发性硬化症的疾病修正治疗——应用重新设定基线概念的证据。
Mult Scler. 2024 Aug;30(9):1128-1138. doi: 10.1177/13524585241267257. Epub 2024 Aug 7.
2
Retinal layer thinning predicts treatment failure in relapsing multiple sclerosis.视网膜层变薄预示着复发型多发性硬化症的治疗失败。
Eur J Neurol. 2021 Jun;28(6):2037-2045. doi: 10.1111/ene.14829. Epub 2021 Apr 2.
3
Disease-modifying therapies modulate retinal atrophy in multiple sclerosis: A retrospective study.疾病修饰疗法可调节多发性硬化症中的视网膜萎缩:一项回顾性研究。
Neurology. 2017 Feb 7;88(6):525-532. doi: 10.1212/WNL.0000000000003582. Epub 2017 Jan 11.
4
A prospective study of disease modifying therapy and retinal atrophy in relapsing-remitting multiple sclerosis.一项关于复发缓解型多发性硬化症中疾病修饰疗法与视网膜萎缩的前瞻性研究。
J Neurol Sci. 2023 Mar 15;446:120552. doi: 10.1016/j.jns.2023.120552. Epub 2023 Jan 19.
5
Long-Term Stability of Neuroaxonal Structure in Alemtuzumab-Treated Relapsing-Remitting Multiple Sclerosis Patients.长效单抗治疗复发性多发性硬化症患者的神经轴突结构稳定性。
J Neuroophthalmol. 2020 Mar;40(1):37-43. doi: 10.1097/WNO.0000000000000802.
6
Baseline retinal nerve fiber layer thickness and macular volume quantified by OCT in the North American phase 3 fingolimod trial for relapsing-remitting multiple sclerosis.在北美 3 期芬戈莫德治疗复发缓解型多发性硬化症的临床试验中,OCT 定量分析视网膜神经纤维层厚度和黄斑体积的基础值。
J Neuroophthalmol. 2013 Dec;33(4):322-9. doi: 10.1097/WNO.0b013e31829c51f7.
7
Predictors of retinal atrophy in multiple sclerosis: A longitudinal study using spectral domain optical coherence tomography with segmentation analysis.多发性硬化症中视网膜萎缩的预测因素:应用谱域光学相干断层扫描结合分割分析的纵向研究。
Mult Scler Relat Disord. 2018 Apr;21:56-62. doi: 10.1016/j.msard.2018.02.010. Epub 2018 Feb 11.
8
Retinal layer thinning as a biomarker of long-term disability progression in multiple sclerosis.视网膜层变薄作为多发性硬化症长期残疾进展的生物标志物。
Mult Scler. 2022 Oct;28(12):1871-1880. doi: 10.1177/13524585221097566. Epub 2022 Jun 2.
9
Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis.复发缓解型与进展型多发性硬化症的光学相干断层扫描分割分析
PLoS One. 2017 Feb 13;12(2):e0172120. doi: 10.1371/journal.pone.0172120. eCollection 2017.
10
Progressive Multiple Sclerosis Is Associated with Faster and Specific Retinal Layer Atrophy.进行性多发性硬化症与更快和更特定的视网膜层萎缩有关。
Ann Neurol. 2020 Jun;87(6):885-896. doi: 10.1002/ana.25738. Epub 2020 Apr 28.

引用本文的文献

1
Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical threshold.视网膜变薄可区分复发型多发性硬化症低于临床阈值的治疗效果。
Ann Clin Transl Neurol. 2025 Feb;12(2):345-354. doi: 10.1002/acn3.52279. Epub 2024 Dec 16.
2
Paramagnetic rim lesions are associated with inner retinal layer thinning and progression independent of relapse activity in multiple sclerosis.顺磁性边缘病变与多发性硬化症中视网膜内层变薄及病情进展相关,且与复发活动无关。
Eur J Neurol. 2025 Jan;32(1):e16529. doi: 10.1111/ene.16529. Epub 2024 Nov 12.